Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% Atropine '5+3' Regimen for Myopia Control in Children and Adolescents
NCT05448989Phase 4Unknown
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atropine in myopia. Status: unknown.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05448989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05448989.